NCELL Technology

The difference is in the delivery

Only CEQUA™ is formulated with an advancement in chronic dry eye treatment––NCELL™ Technology.

NCELL Technology delivers medicine right where your eyes need it most. Once delivered, CEQUA starts to treat inflammation, the underlying cause of chronic dry eye.

How CEQUA Delivers

A drop of CEQUA going into an eye and NCELL Technology encapsulating the active ingredient (cyclosporine), shown as blue dots. A drop of CEQUA going into an eye and NCELL Technology encapsulating the active ingredient (cyclosporine), shown as blue dots.

IT SURROUNDS

It all starts with our unique delivery system, NCELL Technology, which acts to surround the active ingredient in CEQUA, cyclosporine.

NCELL Technology delivering cyclosporine through the tear film onto the surface of the eye. NCELL Technology delivering cyclosporine through the tear film onto the surface of the eye.

IT PENETRATES

This exclusive encapsulation allows the cyclosporine to travel through the layers of the tear film, onto the surface of the eye.

Visual representation of how medicine is released right where it is needed most (onto the surface of the eye). Visual representation of how medicine is released right where it is needed most (onto the surface of the eye).

IT WORKS

Once CEQUA reaches the surface of the eye, medicine is released right where it is needed most. From there, it goes to work on inflammation.

NCELL Technology delivers more medicine to the very part
of your eyes that need it most.*

*In a study of animals treated with cyclosporine 0.5% with NCELL Technology vs cyclosporine 0.5% alone (Restasis®, Allergan), those treated with cyclosporine with NCELL absorbed up to 3x more cyclosporine into different portions of the eye.

Ready to start CEQUA, but not sure where to turn? Find a doctor nearby to get all your questions answered.

FIND A DOCTOR

Important Safety Information

WHAT IS CEQUA?

CEQUA™ (cyclosporine ophthalmic solution) 0.09% is a topical solution that helps to increase the production of natural tears in your eye. Dry eye disease may affect the ability of your eyes to produce its own tears.

IMPORTANT SAFETY INFORMATION

Do not use CEQUA if you are allergic to any of its ingredients. Be careful not to allow the vial tip to touch your eye or any surfaces, to help avoid potential eye injury or contamination of the product.

CEQUA should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to using CEQUA and may be reinserted after 15 minutes.

Put one drop of CEQUA twice daily (approximately 12 hours apart) into each eye using a single-use vial. The solution should be used immediately after opening, and discard the vial and remaining contents immediately after using.

The most common side effects that may be experienced while using CEQUA include: eye pain after administering drops and eye redness. Other side effects reported were eye irritation, eyelid inflammation, headache, and urinary tract infection.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see the Full Prescribing Information.